Sheel Biotech IPO GMP: Day 3 IPO Live Updates

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Fri Oct 03 2025

Sheel Biotech IPO GMP: Day 3 IPO Live Updates

Click & Sign Up to Get Latest Updates on Sheel Biotech IPO

The Sheel Biotech IPO GMP is ₹4 as of 3rd October 2025. It is a book-building IPO of ₹34.02 crores, comprising a fresh issue of 0.54 crores shares. The issue will be listed on NSE and SME on its tentative listing date, 8th October 2025. The face value of Sheel Biotech shares stands at ₹10 per share, and the IPO price band is set at ₹59 to ₹63 per share. Retail investors can bid for a minimum of 2 lots of 4,000 shares worth ₹2,52,000.

Table of Contents

Sheel Biotech IPO Grey Market Premium

As of 3rd October 2025, the Sheel Biotech IPO GMP stands at ₹4 per share. Thus, the estimated listing price would be ₹67. This indicates that the estimated listing gain in this IPO could be 6.35%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Sheel Biotech IPO GMP updates.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
3-20-2025	₹63.00	₹4.00	₹67.00	6.35%
2-10-2025	₹63.00	₹4.00	₹67.00	6.35%
1-10-2025	₹63.00	₹4.00	₹67.00	6.35%
30-09-2025	₹63.00	₹0.00	₹63.00	0.00%
29-09-2025	₹63.00	₹0.00	₹63.00	0.00%
28-09-2025	₹63.00	₹0.00	₹63.00	0.00%
27-09-2025	₹63.00	₹0.00	₹63.00	0.00%
26-09-2025	₹63.00	₹0.00	₹63.00	0.00%

Sheel Biotech IPO Details

IPO Open Date	30th September 2025
IPO Close Date	3rd October 2025
IPO Allotment Date	6th October 2025
Refund Initiation	7th October 2025
Issue Size	54,00,000 shares(aggregating up to ₹34.02 Cr)
Face Value	₹10 per share
Lot Size	1,600 shares
Issue Price Final	₹129 and ₹136 per share
Issue Type	Bookbuilding IPO
Listing At	NSE & SME
Listing Date	8th October 2025

Explanation

Sheel Biotech IPO: Sheel Biotech Limited has announced that the issue price is set at ₹59 to ₹63 per share. With this IPO, the company allows retail investors to bid for two lots of 4,000 shares worth ₹2,52,000. The face value of Sheel Biotech Limited shares is ₹10 per share. The shares of Sheel Biotech Limited will be listed on BSE and SME on its tentative listing day, 8th October 2025. Scroll down to view GMP updates and reviews of the Sheel Biotech IPO.

Objectives of the Sheel Biotech IPO

The primary aim of the Sheel Biotech IPO is to raise ₹34.02 crore. On the other hand, Sheel Biotech has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Sheel Biotech IPO.

To Capital Expenditure Requirement
To Working Capital Requirement
To General Corporate Purposes

Sheel Biotech IPO Registrar

Skyline Financial Services Private Limited is the registrar of the Sheel Biotech IPO, responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Sheel Biotech allotment and refund, you can contact Skyline Financial Services Private Limited at compliances@skylinerta.com or 02228511022.

Sheel Biotech IPO Review

The Sheel Biotech IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Sheel Biotech Limited’s revenue increased by 15.41% from ₹80.19 crore in March 2023 to ₹ 92.55 crore in March 2024. Moreover, the company’s PAT rose by 106.89% from ₹5.08 crores to ₹10.51 crores.

Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Sheel Biotech IPO or not.

Sheel Biotech Limited Technicals

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Sheel Biotech IPO.

Key Indicators	Value
PE Ratio (Price-to-Earnings)	8.96
EPS (Earnings Per Share)	7.03
RoNW	13.59%
ROCE	16.34%
ROE	13.59%
EBITDA Margin	14.71%
Price to Book Value	1.26
Market Capitalisation	₹128.22 Cr.

The P/E ratio of Sheel Biotech Limited’s share is 8.96, and its Earnings Per Share (EPS) stands at 7.03. Thus, the Sheel Biotech Limited IPO can deliver gains on its tentative listing date, 8th October 2025.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Sheel Biotech Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	8.96	44.07
EPS	7.03	1.43

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

FAQs on Sheel Biotech IPO

What is the GMP of the Sheel Biotech IPO?

Ans. As of 3rd October 2025, the Sheel Biotech (Grey Market Premium) stands at ₹4. This suggests that the estimated listing price could be ₹67 per share.

What is the issue price of the Sheel Biotech IPO?

Ans. The Sheel Biotech IPO price is set between ₹59 and ₹63 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 4,000 shares, worth ₹2,52,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth ₹3,78,000

Who is the registrar of the Sheel Biotech IPO?

Ans Skyline Financial Services Private Limited is the registrar of the Sheel Biotech IPO, responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Sheel Biotech allotment and refund, you can contact Skyline Financial Services Private Limited at compliances@skylinerta.com or 02228511022.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Sheel Biotech IPO, download the Sheel Biotech IPO RHP and Sheel Biotech IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.